Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

Stock Quote

NASDAQCRDF
$1.39
NASDAQCRDF
Open
$1.41
Change
-$0.04 (-2.80%)
Day's Range
$1.31 - $1.41
52-Week Range
$1.20 - $2.79
Volume
1.3M
Market Cap
$62.1M